about
Contemporary murine models in preclinical astrocytoma drug developmentTherapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylationTransformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation processHIF1α and HIF2α independently activate SRC to promote melanoma metastasesMERTK receptor tyrosine kinase is a therapeutic target in melanoma.ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinomaαB-crystallin: a novel regulator of breast cancer metastasis to the brainGenome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.Application of molecular biology studies to gene therapy treatment strategies.Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy.Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaAn animal model of MYC-driven medulloblastomaASC deficiency suppresses proliferation and prevents medulloblastoma incidenceEffects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis.LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaCore pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma.Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastomaGray zones in brain tumor classification: evolving concepts.Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice.Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization.Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer.Cerebellar granule neuron progenitors are the source of Hk2 in the postnatal cerebellum.Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
P50
Q27026937-2E70660C-4B3E-4A88-8A22-DA0B6A71D475Q27333831-E3E5B841-B810-49BF-8659-F803E38134E1Q28730029-AC651543-6A01-407F-BF6E-C04955EF6A4BQ30405908-D96837BC-2CC7-4E22-8B52-B30049615D66Q30539170-AE988118-F85B-4A1F-AF16-06C3E718501CQ30539324-56072FBE-4754-4801-8EC2-16BE371E35AFQ33758217-3FDAAA0D-E7F5-4E2F-8E19-C2E6E82E7B04Q34378205-8F39911C-2262-47A9-9B13-EE2238ABBAD7Q34577891-653CAC3D-5D79-47A1-A631-57FB8F2E25E8Q34605099-9E461BD4-2E9F-4195-95C2-076F9AACE67BQ34627868-CC24EA70-A980-4607-975B-9F0CD7AF6581Q34708283-D358AD7D-1C20-427A-8238-F7665D0ACE97Q35374807-615A3979-A39C-4973-84D7-07D7152E86ABQ35564248-655C9284-8F56-4510-A914-BC244A0099E3Q35774418-36F70463-DD16-4BA7-B7BA-FCDDAD48B959Q35904348-0BA0D59B-21C5-49A1-B1AE-F64BC36E52E4Q36047366-3C321E35-8FCC-4296-B020-B9DC1B24ED3EQ36107356-A7ED1C89-68CD-419D-9461-A664ED9B8F1FQ36865568-AF4B1768-5152-42EE-A67C-3F05EFC9DCC1Q36977690-E359F613-521C-43CE-BD3C-F836CE5431D5Q37050088-B21973A7-880E-4368-9321-2A2F7BF0DCF8Q37196742-360F7D21-530C-4593-B027-38863EA7D46FQ37250947-1C18C337-B6F6-4DF6-B8B1-8F85288366F5Q37265523-85D89607-5276-48FA-AB27-7B8B25EFFE00Q37424400-699B0A97-D869-4159-84D2-303E03B86FBCQ37524229-161482C8-5ECD-4F6B-89F0-934F30B671E0Q38168686-BECC5F98-D9A1-4CF5-8C2D-CD9E06403E8BQ38764607-8CC052EA-CE09-497D-B04E-D58AE7D6E1E1Q38766447-CE0303CC-E392-451E-B4BB-F98AA377A3B0Q38963855-D7B1102B-BCE3-47F1-AB04-D6447A346CBBQ40470907-096BC968-4B26-46BC-B8DC-16ADC2FAF572Q41929512-E4DEAA85-07E1-4A80-951A-DE1FC9D9D319Q42919775-A19785FF-C429-4948-BB20-F083E6A6F71BQ43805719-6B7DC717-E32E-4B77-B8F4-429D134E253CQ46614852-8C8A7913-579E-43B0-93CC-6D0021299138Q47851037-EFA31B24-5D26-4BC9-AE34-460E862D4FAEQ48225985-FC8B6D5F-BC63-442A-9BCB-2BD252AE3273Q48229251-A85FDE71-27AA-42E6-A742-0F5E73267263Q48329121-3628AA07-0B6D-4808-A818-056577FA5EC2Q48352434-363540EF-DB4E-4CEE-86A4-8E289A1F526E
P50
description
Amerikaans onderzoeker
@nl
researcher ORCID id 0000-0002-0096-8762
@en
name
C. Ryan Miller
@ast
C. Ryan Miller
@en
C. Ryan Miller
@es
C. Ryan Miller
@nl
type
label
C. Ryan Miller
@ast
C. Ryan Miller
@en
C. Ryan Miller
@es
C. Ryan Miller
@nl
prefLabel
C. Ryan Miller
@ast
C. Ryan Miller
@en
C. Ryan Miller
@es
C. Ryan Miller
@nl
P1053
B-9365-2008
P106
P2798
P31
P3829
P496
0000-0002-0096-8762